A 50-year old, very commonly used class of blood pressure drugs may have some very unexpected baggage. There are about 100 million prescriptions written for calcium channel blockers
Today we have an example of some breast lesions atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) that may require such a redefinition under some circumstances.
It has long been known that there are disparities in health care between black women and white women, specifically in women with breast cancer. A new study,
The American Society of Clinical Oncology took a major step towards making progress in preventing breast cancer and updated their 2009 guidelines. The updates include recommendations that tamoxifen and raloxifene (Evista) should be discussed as options to reduce risk of invasive, ER-positive breast cancer in pre- and post-menopausal women at higher than usual risk of the disease, instead of simply may be discussed.
Metastatic breast cancer which has already spread on initial presentation was found to have increased slightly among young women, ages 25 to 39, a 34-year analysis suggests. More research is needed to verify the finding, and scientists are not sure what may have caused the apparent increase.
Many breast cancer nonprofits are attempting to attract public interest and generate support by exploiting commonly-held fears of chemicals as possible causes of breast cancer, a review by the American Council on Science and Health has found. The association between chemicals and breast cancer is discredited by a majority of the scientific community.
Introduction As the year draws to a close, some of us will be reminded that olde acquaintance should not be forgot. So, before we can officially commence the New Year, the American Council on Science and Health would like to reflect upon this year past. We d especially like to spend an extra moment considering what we hope the world will eventually learn to forget the most unfounded health scares of 2007. What were these? Not all of them were so novel. Just as old habits die hard, old scares don t seem to disappear easily either, and some headlines that received noted media attention in years past have reared their ugly heads once more in this current publication of our annual list of health scares.
EXECUTIVE SUMMARY A wide variety of factors may influence an individual's likelihood of developing various types of cancer. These factors are usually referred to as risk factors. Different types of cancer may have different risk factors.
EXECUTIVE SUMMARY 1. The U.S. Food and Drug Administration has approved the drug tamoxifen for breast cancer risk reduction in high-risk women. This is the first time that any drug has been approved for cancer chemoprevention. 2. Several studies in high-risk women have shown that the use of tamoxifen may reduce a woman's risk of breast cancer by 40-50 percent.
To the Editor: The column "Keeping Breast Cancer in Perspective" conveys a cogent and long overdue message to women: there is no epidemic of breast cancer in this country. Rather, it is the fear of breast cancer not the disease itself, that has reached epidemic proportions. The positive effort to increase public awareness of breast cancer has had the unfortunate effect of distorting women's perceptions of breast cancer risk.
The onset of menopause presents a complex set of questions to many women. One of those questions may be whether or not to begin hormone replacement therapy (HRT).